Jet Medical, a medical device distributor, has reached an agreement to pay the U.S. government $200,000 to resolve misbranding allegations surrounding a migraine treatment, according to a Jan. 5 report from Medscape.
Jet Medical, a medical device distributor, has reached an agreement to pay the U.S. government $200,000 to resolve misbranding allegations surrounding a migraine treatment, according to a Jan. 5 report from Medscape.